| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Drs. Chang, Ernst, Leonido–Yee, and Speck), Radiology (Drs. Ernst and Walot), Medicine (Dr. Witt), and Psychiatry (Dr. Miller), University of California at Los Angeles School of Medicine, Harbor-UCLA Medical Center, Torrance, CA.
Address correspondence and reprint requests to Dr. Linda Chang, Department of Neurology, 1124 W. Carson Street, B-4, Harbor-UCLA Medical Center, Torrance, CA 90502; e-mail: Linda_Chang{at}humc.edu
OBJECTIVE: To determine whether cerebral metabolite abnormalities normalize with highly active antiretroviral therapy (HAART).
BACKGROUND: Patients with HIV–cognitive motor complex (HIV-CMC) show cerebral metabolite abnormalities in the early stages of dementia.
METHODS: Sixteen patients with HIV-CMC were evaluated before and after HAART, and compared with 15 HIV-negative healthy volunteers. Cerebral metabolite ratios and concentrations in the frontal lobe and basal ganglia were measured using proton MRS (1H MRS).
RESULTS: In 14 of 16 patients who tolerated HAART, CD4 count increased by 133 ± 101 cells/mm3 (p = 0.0003), HIV Dementia Scale score increased by 1.8 ± 2.4 points (p = 0.02), and AIDS dementia complex (ADC) stage decreased by 0.54 ± 0.54 points (p = 0.003). The initially increased choline/creatine (CHO/CR) reversed in the midfrontal cortex (-8.0%; p = 0.02) and in the basal ganglia (-14.7%; p = 0.01). The initially elevated myoinositol (MI)/CR and myoinositol concentration [MI] in the basal ganglia also decreased (
MI/CR: -14.1%; p = 0.005; [MI]: 11.8%; p = 0.02), along with normalization of [MI] in the frontal white matter (11.4%; p = 0.05). Furthermore, the change in [MI] in the frontal white matter correlated with the change in CD4 count (r = -0.67, p = 0.03) and with the change in ADC stage (p = 0.04).
CONCLUSIONS: HAART improves HIV-CMC in addition to systemic measures of HIV infection. 1H MRS detects improvement of brain injury measured by cerebral metabolites, particularly the glial marker [MI], in patients with early HIV-CMC after HAART. In addition, the degree of improvement in clinical severity of HIV-CMC is related to the degree of recovery with [MI].
Key words: MRI—MRS—HIV dementia—Highly active antiretroviral therapy—Metabolites.
This article has been cited by other articles:
|
|
 |
|
  M. R. Lentz, W. K. Kim, V. Lee, S. Bazner, E. F. Halpern, N. Venna, K. Williams, E. S. Rosenberg, and R. G. Gonzalez Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection Neurology, April 28, 2009; 72(17): 1465 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Kolson YKL-40: A Candidate Biomarker for Simian Immunodeficiency Virus and Human Immunodeficiency Virus Encephalitis? Am. J. Pathol., July 1, 2008; 173(1): 25 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Repetto and J. M. Petitto Psychopharmacology in HIV-Infected Patients Psychosom Med, June 1, 2008; 70(5): 585 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Pomper and N. Sacktor New Techniques for Imaging Human Immunodeficiency Virus Associated Cognitive Impairment in the Era of Highly Active Antiretroviral Therapy Arch Neurol, September 1, 2007; 64(9): 1233 - 1235. [Full Text] [PDF]
|
|
|
|
|
|
A. C. Roc, B. M. Ances, S. Chawla, M. Korczykowski, R. L. Wolf, D. L. Kolson, J. A. Detre, and H. Poptani Detection of Human Immunodeficiency Virus Induced Inflammation and Oxidative Stress in Lenticular Nuclei With Magnetic Resonance Spectroscopy Despite Antiretroviral Therapy Arch Neurol, September 1, 2007; 64(9): 1249 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Paul, C. T. Yiannoutsos, E. N. Miller, L. Chang, C. M. Marra, G. Schifitto, T. Ernst, E. Singer, T. Richards, G. J. Jarvik, et al. Proton MRS and Neuropsychological Correlates in AIDS Dementia Complex: Evidence of Subcortical Specificity J Neuropsychiatry Clin Neurosci, August 1, 2007; 19(3): 283 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gabis, A. Belman, Wei Huang, M. Milazzo, and S. Nachman Clinical and Imaging Study of Human Immunodeficiency Virus-1--Infected Youth Receiving Highly Active Antiretroviral Therapy: Pilot Study Using Magnetic Resonance Spectroscopy J Child Neurol, June 1, 2006; 21(6): 485 - 490. [Abstract] [PDF]
|
|
|
|
|
|
M. A. Keller, T. N. Venkatraman, M. A. Thomas, A. Deveikis, C. LoPresti, J. Hayes, N. Berman, I. Walot, T. Ernst, and L. Chang Cerebral metabolites in HIV-infected children followed for 10 months with 1H-MRS Neurology, March 28, 2006; 66(6): 874 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schifitto, D. R. Peterson, J. Zhong, H. Ni, K. Cruttenden, M. Gaugh, H. E. Gendelman, M. Boska, and H. Gelbard Valproic acid adjunctive therapy for HIV-associated cognitive impairment: A first report Neurology, March 28, 2006; 66(6): 919 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Ferrando and C. Nims HIV-Associated Mania Treated With Electroconvulsive Therapy and Highly-Active Antiretroviral Therapy. Psychosomatics, March 1, 2006; 47(2): 170 - 174. [Full Text] [PDF]
|
|
|
|
|
|
H.-J. von Giesen, B. A. Haslinger, S. Rohe, H. Koller, and G. Arendt HIV Dementia Scale and Psychomotor Slowing--The Best Methods in Screening for Neuro-AIDS J Neuropsychiatry Clin Neurosci, May 1, 2005; 17(2): 185 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Lentz, J. P. Kim, S. V. Westmoreland, J. B. Greco, R. A. Fuller, E. M. Ratai, J. He, P. K. Sehgal, E. F. Halpern, A. A. Lackner, et al. Quantitative Neuropathologic Correlates of Changes in Ratio of N-acetylaspartate to Creatine in Macaque Brain Radiology, May 1, 2005; 235(2): 461 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. McArthur, M. P. McDermott, D. McClernon, C. St Hillaire, K. Conant, K. Marder, G. Schifitto, O. A. Selnes, N. Sacktor, Y. Stern, et al. Attenuated Central Nervous System Infection in Advanced HIV/AIDS With Combination Antiretroviral Therapy Arch Neurol, November 1, 2004; 61(11): 1687 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Keller, T. N. Venkatraman, A. Thomas, A. Deveikis, C. LoPresti, J. Hayes, N. Berman, I. Walot, S. Padilla, J. Johnston-Jones, et al. Altered neurometabolite development in HIV-infected children: Correlation with neuropsychological tests Neurology, May 25, 2004; 62(10): 1810 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Ragin, P. Storey, B. A. Cohen, L. G. Epstein, and R. R. Edelman Whole Brain Diffusion Tensor Imaging in HIV-Associated Cognitive Impairment AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wenserski, H.-J. von Giesen, H.-J. Wittsack, A. Aulich, and G. Arendt Human Immmunodeficiency Virus 1-associated Minor Motor Disorders: Perfusion-weighted MR Imaging and H MR Spectroscopy Radiology, July 1, 2003; 228(1): 185 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Ferrando, J. G. Rabkin, W. van Gorp, S.-H. Lin, and M. McElhiney Longitudinal Improvement in Psychomotor Processing Speed Is Associated With Potent Combination Antiretroviral Therapy in HIV-1 Infection J Neuropsychiatry Clin Neurosci, May 1, 2003; 15(2): 208 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.H. Hinkin, S.A. Castellon, R.S. Durvasula, D.J. Hardy, M.N. Lam, K.I. Mason, D. Thrasher, M.B. Goetz, and M. Stefaniak Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity Neurology, December 24, 2002; 59(12): 1944 - 1950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ernst, L. Chang, J. Jovicich, N. Ames, and S. Arnold Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients Neurology, November 12, 2002; 59(9): 1343 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Patel, D. L. Kolson, G. Glosser, I. Matozzo, Y. Ge, J. S. Babb, L. J. Mannon, and R. I. Grossman Correlation between Percentage of Brain Parenchymal Volume and Neurocognitive Performance in HIV-Infected Patients AJNR Am. J. Neuroradiol., April 1, 2002; 23(4): 543 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chang, O. Speck, E. N. Miller, J. Braun, J. Jovicich, C. Koch, L. Itti, and T. Ernst Neural correlates of attention and working memory deficits in HIV patients Neurology, September 25, 2001; 57(6): 1001 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. von Giesen, H.-J. Wittsack, F. Wenserski, H. Koller, H. Hefter, and G. Arendt Basal Ganglia Metabolite Abnormalities in Minor Motor Disorders Associated With Human Immunodeficiency Virus Type 1 Arch Neurol, August 1, 2001; 58(8): 1281 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Filippi, A. M. Ulu, E. Ryan, S. J. Ferrando, and W. van Gorp Diffusion Tensor Imaging of Patients with HIV and Normal-appearing White Matter on MR Images of the Brain AJNR Am. J. Neuroradiol., February 1, 2001; 22(2): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Stankoff, A. Tourbah, S. Suarez, E. Turell, J.L. Stievenart, C. Payan, A. Coutellier, S. Herson, L. Baril, F. Bricaire, et al. Clinical and spectroscopic improvement in HIV-associated cognitive impairment Neurology, January 9, 2001; 56(1): 112 - 115. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
